LUNG

4.76

5.31% 0.24

Handel nachbörslich: 4.76

Pulmonx Corp (LUNG)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$4.52

Offen:

$4.52

24-Stunden-Volumen:

268.72K

Relative Volume:

0.79

Marktkapitalisierung:

$198.02M

Einnahmen:

$68.68M

Nettoeinkommen (Verlust:

$-60.84M

KGV:

-2.975

EPS:

-1.6

Netto-Cashflow:

$-38.42M

1W Leistung:

-3.25%

1M Leistung:

-38.74%

6M Leistung:

-22.35%

1J Leistung:

-35.68%

1-Tages-Spanne:

$4.41

$4.835

1-Wochen-Bereich:

$4.15

$5.16

52-Wochen-Spanne:

$4.15

$10.01

Pulmonx Corp Stock (LUNG) Company Profile

Firmenname

Pulmonx Corp

Sektor

Healthcare (1153)

Branche

Medical Devices (154)

Telefon

650-364-0400

Adresse

700 CHESAPEAKE DRIVE, REDWOOD CITY

Mitarbeiter

291

Twitter

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

LUNG's Discussions on Twitter

Vergleichen Sie LUNG mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LUNG Pulmonx Corp	4.76	198.02M	68.68M	-60.84M	-38.42M	-1.60
ABT Abbott Laboratories	131.73	218.91B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.05	139.37B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	348.12	134.90B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	83.37	106.90B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	70.60	41.45B	5.72B	4.17B	259.90M	6.97

Pulmonx Corp Stock (LUNG) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-10	Eingeleitet	D. Boral Capital	Buy
2024-12-11	Herabstufung	Citigroup	Buy → Neutral
2024-06-04	Eingeleitet	Lake Street	Buy
2024-02-23	Herabstufung	Wells Fargo	Overweight → Equal Weight
2023-09-05	Eingeleitet	Craig Hallum	Buy
2023-02-27	Hochstufung	Wells Fargo	Equal Weight → Overweight
2023-01-03	Herabstufung	BofA Securities	Neutral → Underperform
2022-12-12	Hochstufung	Citigroup	Neutral → Buy
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Neutral
2021-12-08	Hochstufung	Piper Sandler	Neutral → Overweight
2021-04-01	Eingeleitet	Citigroup	Buy
2021-03-25	Eingeleitet	Piper Sandler	Neutral
2021-03-10	Hochstufung	BofA Securities	Neutral → Buy
2021-01-04	Herabstufung	BofA Securities	Buy → Neutral
2020-10-26	Eingeleitet	BofA Securities	Buy
2020-10-26	Eingeleitet	Canaccord Genuity	Buy
2020-10-26	Eingeleitet	Morgan Stanley	Equal-Weight
2020-10-26	Eingeleitet	Stifel	Buy
2020-10-26	Eingeleitet	Wells Fargo	Equal Weight

Alle ansehen

Pulmonx Corp Aktie (LUNG) Neueste Nachrichten

02:43 AM

Pulmonx Co. (NASDAQ:LUNG) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

02:43 AM

Apr 18, 2025

Pulmonx stock plunges to 52-week low of $5.38 amid market challenges - Investing.com Nigeria

Apr 18, 2025

Vanguard Group Inc. Grows Stock Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World

Apr 18, 2025

Apr 17, 2025

Pulmonx stock plunges to 52-week low, hitting 4.71 USD By Investing.com - Investing.com Canada

Apr 17, 2025

Pulmonx stock plunges to 52-week low, hitting 4.71 USD - Investing.com Australia

Apr 17, 2025

Apr 16, 2025

Leading Lung Treatment Innovator Pulmonx Announces Q1 2025 Earnings Date - Stock Titan

Apr 16, 2025

Apr 14, 2025

American Century Companies Inc. Grows Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World

Apr 14, 2025

Apr 13, 2025

151,200 Shares in Pulmonx Co. (NASDAQ:LUNG) Acquired by Norges Bank - Defense World

Apr 13, 2025

Apr 09, 2025

Pulmonx stock plunges to 52-week low of $5.38 amid market challenges By Investing.com - Investing.com South Africa

Apr 09, 2025

Mar 29, 2025

Charles Schwab Investment Management Inc. Boosts Holdings in Pulmonx Co. (NASDAQ:LUNG) - Defense World

Mar 29, 2025

Mar 28, 2025

Pulmonx Co. (NASDAQ:LUNG) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 28, 2025

Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Buys 25,988 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World

Mar 23, 2025

Mar 22, 2025

Insider Sell Alert: French Glendon E. III Sells 20,000 Shares of Pulmonx Corp (LUNG) - GuruFocus

Mar 22, 2025

Pulmonx corp director Glendon French sells $157,000 in stock By Investing.com - Investing.com Canada

Mar 22, 2025

Mar 21, 2025

Pulmonx corp director Glendon French sells $157,000 in stock - Investing.com

Mar 21, 2025

Canaccord maintains Buy rating on Pulmonx stock with $16 target By Investing.com - Investing.com Australia

Mar 21, 2025

Canaccord maintains Buy rating on Pulmonx stock with $16 target - Investing.com

Mar 21, 2025

Mar 10, 2025

Boral Capital sets Pulmonx stock Buy rating, $17 target - Investing.com India

Mar 10, 2025

Boral Capital sets Pulmonx stock Buy rating, $17 target By Investing.com - Investing.com South Africa

Mar 10, 2025

This Pulmonx Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Mar 10, 2025

Pulmonx initiated with a Buy at D. Boral Capital - TipRanks

Mar 10, 2025

Mar 09, 2025

Pulmonx (NASDAQ:LUNG) vs. Spectral Medical (OTCMKTS:EDTXF) Financial Review - The AM Reporter

Mar 09, 2025

Mar 07, 2025

Reviewing Pulmonx (NASDAQ:LUNG) & Spectral Medical (OTCMKTS:EDTXF) - Defense World

Mar 07, 2025

Mar 06, 2025

Pulmonx corp’s chief commercial officer sells $41,191 in stock - Investing.com India

Mar 06, 2025

Pulmonx corp general counsel sells shares totaling $170,918 - Investing.com India

Mar 06, 2025

Mar 05, 2025

Pulmonx CFO Mehul Joshi sells $102,414 in stock By Investing.com - Investing.com Australia

Mar 05, 2025

Pulmonx Corp CEO Steven Williamson sells $197,699 in stock - Investing.com India

Mar 05, 2025

Pulmonx CFO Mehul Joshi sells $102,414 in stock - Investing.com India

Mar 05, 2025

Pulmonx corp’s chief commercial officer sells $41,191 in stock By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 03, 2025

Can This Medical Device Expert Help EDAP Dominate the $8.5B Prostate Cancer Market? - StockTitan

Mar 03, 2025

Pulmonx Co. (NASDAQ:LUNG) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Mar 03, 2025

Mar 01, 2025

Pulmonx director French Glendon E. III sells shares worth $29,625 - MSN

Mar 01, 2025

Feb 24, 2025

Pulmonx director French Glendon E. III sells $459,085 in shares By Investing.com - Investing.com Canada

Feb 24, 2025

Pulmonx director French Glendon E. III sells $459,085 in shares - Investing.com India

Feb 24, 2025

Feb 21, 2025

Pulmonx Corporation shares spike on record-breaking Q4 revenue - Mugglehead

Feb 21, 2025

Stock summary: Pulmonx witnessed weekly surge of 20.43% after fourth-quarter earnings exceed expectations - Business Upturn

Feb 21, 2025

Feb 20, 2025

Top 3 Health Care Stocks You May Want To Dump In February - Benzinga

Feb 20, 2025

Pulmonx Corporation (NASDAQ:LUNG) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 20, 2025

Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 20, 2025

Citi raises Pulmonx stock target following record revenue - Investing.com India

Feb 20, 2025

Citi raises Pulmonx stock target following record revenue By Investing.com - Investing.com Nigeria

Feb 20, 2025